Edition:
United States

Zhejiang Huahai Pharmaceutical Co Ltd (600521.SS)

600521.SS on Shanghai Stock Exchange

20.62CNY
21 Sep 2018
Change (% chg)

¥0.36 (+1.78%)
Prev Close
¥20.26
Open
¥20.54
Day's High
¥20.73
Day's Low
¥19.93
Volume
9,832,390
Avg. Vol
12,630,477
52-wk High
¥32.83
52-wk Low
¥17.28

Select another date:

Mon, Sep 17 2018

Photo

Global health regulators find second toxin in common heart drug

(This version of the September 14th story changes final paragraph to show representative did not immediately respond to a request for comment)

Toxin at heart of drug recall shows holes in medical safety net

SHANGHAI/LONDON A toxin inadvertently produced in the manufacture of a widely prescribed medicine but not spotted for years raises questions about regulators' ability to detect risks in a sprawling global drug supply chain increasingly reliant on factories in China.

China tells medical institutions to stop using Huahai heart drug

SHANGHAI China's health regulator has ordered local medical institutions to stop using a heart drug from Zhejiang Huahai Pharmaceutical Co Ltd, in a directive that comes just days after another case of a tainted medical product.

UPDATE 3-China tells medical institutions to stop using Huahai heart drug

* Chinese drugmaker stocks trade lower (Recasts; adds analyst comment)

China orders medical institutions not to use recalled valsartan drug

SHANGHAI, July 30 China's health regulator has called on all medical institutions to cooperate with authorities and not use the valsartan blood and heart drug that is said to pose cancer risks.

Select another date: